BMY insider buying and SEC filings, explained
Bristol Myers Squibb Co. · CIK 14272
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$437K
Planned sales (10b5-1)
$1.9M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 9, 2026 | Sale | Cristian Massacesi (EVP,Chief Med Offr,Head of Dev) sold 6,249 shares at $64.57 ($403K). Holdings down 25% to 18,748 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 10, 2026 |
| Aug 25, 2026 | Sale | Phil M Holzer (SVP and Controller) sold 500 shares at $67.50 ($34K). Holdings down 3% to 16,862 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | David V Elkins (CFO) sold 30,000 shares at about $61.67 ($1.9M), marked as a 10b5-1 plan trade. Holdings down 16% to 159,248 shares. | SEC filing Filed Apr 2, 2026 |
62 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BMY in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.